Skip to main content
  1. Home
  2. Emerging Tech
  3. News

Disney wants to stick projectors on drones and fly them in its parks

Add as a preferred source on Google

Disney is considering launching “projector drones” at its parks that would buzz about en masse, beaming images onto attached screens as part of dazzling night-time displays. Or at least, that’s the idea.

The concept, laid out by the entertainment giant in a patent granted this month, could see the modified flying machines used in aerial displays at Disney’s sites in California and Florida.

Recommended Videos

According to diagrams, the drone’s screen would be held parallel to the ground, with the projector beaming an image onto its rear surface via a reflector. The screen would have enough translucency to allow park visitors to see the projection, which could consist of both still and moving images.disney drone

To prevent unexpected wind gusts playing havoc with the screen and compromising the drone’s flying ability, the patent suggests the lightweight surface could be made from “a mesh sheet with a porosity allowing air to flow through.”

The filing explains how the drones could be used en masse for aerial-based entertainment “with floating or flying projection screens” showing changing imagery set to music.

Disney notes that up to now the kinds of visual effects achieved using drone technology have been limited, and so new methods such as its proposed projector drone could take aerial displays in a new direction. In its own words, it says its system aims to “provide a way of radically expanding the palette of the aerial display … to include all manner of imagery and effects.”

The filing also speaks of its projector drones opening “new frontiers for aerial advertising,” and says they could also be used for getting information to visitors quickly in an emergency situation.

Disney made it known earlier this year that drone technology presented new opportunities for the company when it applied to the Federal Aviation Administration for special permission to incorporate the machines into its entertainment program.

Trevor Mogg
Contributing Editor
Not so many moons ago, Trevor moved from one tea-loving island nation that drives on the left (Britain) to another (Japan)…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more